As the country registers an increase in new HIV infections, stakeholders have called for improved access to prevention tools. Recently, Johnson & Johnson (J&J) and Partners announced that the Imbokodo HIV vaccine trial offered no convincing protection against HIV infection, thereby bringing the study to a bleak end. The Imbokodo vaccine, made by Johnson & […]
Source: Leadership Newspaper
Home Leadership Newspapers BACK STORY OF THE DAY: Stakeholders Advocate Improved Access To HIV Prevention...
